J9292 Injection, pemetrexed dipotassium
Also known as: pemetrexed, Alimta
Injection of pemetrexed dipotassium, a multi-targeted antifolate antimetabolite. Used for non-small cell lung cancer and mesothelioma.
In Plain Language
lung cancer injection; mesothelioma treatment
Clinical Context
First-line therapy for nonsquamous non-small cell lung cancer with cisplatin. Also used for malignant pleural mesothelioma and other solid tumors.
RVU Information
CPT J9292 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9292?
CPT J9292 (Injection, pemetrexed dipotassium) is a J Codes (Drugs) code. Injection of pemetrexed dipotassium, a multi-targeted antifolate antimetabolite. Used for non-small cell lung cancer and mesothelioma.
How is J9292 administered?
CPT J9292 is administered by a healthcare provider, typically via injection or infusion. First-line therapy for nonsquamous non-small cell lung cancer with cisplatin. Also used for malignant pleural mesothelioma and other solid tumors. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9292 used?
First-line therapy for nonsquamous non-small cell lung cancer with cisplatin. Also used for malignant pleural mesothelioma and other solid tumors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.